CIRM’s CLIN2 funding program will support the completion of phase 1, 2, or 3 clinical trials— including pivotal trials— for regenerative medicine therapies that address significant unmet medical needs ...

How California Built a Global Powerhouse in Stem Cell and Gene Therapy June 1, 2026 A decision California voters made more than two decades ago helped build an unparalleled scientific ecosystem that’s ...

The objective of this project was to file an Investigational New Drug (IND) application for a clinical trial using embryonic stem cell-derived neural stem cells to treat patients with Huntington’s ...

The goal of this project was to improve the long-term performance of clinical-grade expanded polytetrafluoroethylene (ePTFE) vascular grafts by coating them with a peptide ligand called LXW7. LXW7 is ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

NysnoBio is advancing a gene therapy for Parkinson’s Disease based on human genetic data indicating the Parkin protein is a regenerative factor for neurons that die in Parkinson’s Disease (PD).

Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below. Members of the public attending the meeting at a teleconference location ...

ALS (amyotrophic lateral sclerosis) is a devastating disease that progressively destroys the nerve cells that control movement, eventually taking away a person’s ability to walk, speak, swallow, and ...

South San Francisco, CA, December 11, 2025 – The California Institute for Regenerative Medicine (CIRM) governing board today approved funding of over $160 million for 16 new research awards to develop ...

South San Francisco, Calif., January 30, 2026 – The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, which sets aside ...